Evaluation of the interaction between mirogabalin and proton pump inhibitors via renal tubular transporters

Evaluation of the interaction between mirogabalin and proton pump inhibitors via renal tubular transporters - Evaluation of the interaction between mirogabalin and proton pump inhibitors via renal tubular transporters

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000054409

Enrollment

Registered

2024-05-16

Start date

2022-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: adult patients(Over 20 years old)receiving mirogabalin after thoracic surgery

Exclusion criteria

Exclusion criteria: (1) mirogabalin hypersensitivity, (2) patients who did not consent to participate in the study, (3) patients whose surgery was postponed, and (4) patients who deemed inappropriate by the physician

Design outcomes

Primary

Measure	Time frame
Blood concentration of mirogabalin on days 3 to 5 after administration	—

Countries

Japan

Contacts

Public ContactNaomi Hamaguchi

Mie University Hospital Department of Pharmacy

naomi-h@med.mie-u.ac.jp059-232-1111

Outcome results